AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹3,486 Cr | ₹3,173 Cr | ₹1,928 Cr | ₹2,648 Cr | ₹5,335 Cr |
What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹3,486 Cr |
Mar2024 | ₹3,173 Cr |
Mar2023 | ₹1,928 Cr |
Mar2022 | ₹2,648 Cr |
Mar2021 | ₹5,335 Cr |
How is Consolidated Net Profit of AUROBINDO PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹3,486 Cr | 9.86 | |
Mar2024 | ₹3,173 Cr | 64.62 | |
Mar2023 | ₹1,928 Cr | -27.21 | |
Mar2022 | ₹2,648 Cr | -50.36 | |
Mar2021 | ₹5,335 Cr | - |
Compare Consolidated Net Profit of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹60,417.7 Cr | 1.9% | -3% | -32.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,191.0 Cr | 1% | -0.9% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,973.0 Cr | -1.6% | -1.8% | 17.9% | Stock Analytics | |
CIPLA | ₹124,507.0 Cr | -1.8% | 3.7% | -6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,175.0 Cr | 0.7% | 2.4% | 3.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,355.0 Cr | -0.6% | 4.5% | -6.5% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 1.9% |
-3% |
-32.6% |
SENSEX | 0.5% |
0.1% |
-2.1% |
You may also like the below Video Courses